FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

JONES EVAN/ FA
2. Issuer Name and Ticker or Trading Symbol

OPGEN INC [ OPGN,OPGNW ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 160
3. Date of Earliest Transaction (MM/DD/YYYY)

5/8/2015
(Street)

GAITHERSBURG, MD 20878
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/8/2015     P    445000   A $6.00   445000   I   See footnote   (4)
Common Stock   5/8/2015     C    1059213   A   (1) 1504213   I   See footnote   (4)
Common Stock   5/8/2015     C    749366   A   (2) 2253579   I   See footnote   (4)
Common Stock   5/8/2015     C    675553   A   (2) 2929132   I   See footnote   (4)
Common Stock   5/8/2015     P    8333   A $6.00   8333   I   By spouse  
Common Stock   5/8/2015     C    19011   A   (1) 27344   I   By spouse  
Common Stock   5/8/2015     C    103812   A   (3) 131156   I   By spouse  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Redeemable Convertible Preferred Stock     (1) 5/8/2015     C         1059213      (1)   (1) Common Stock   1059213   $0.00   0   I   See footnote   (4)
Series A Redeemable Convertible Preferred Stock     (1) 5/8/2015     C         19011      (1)   (1) Common Stock   19011   $0.00   0   I   By spouse  
2014 Convertible Notes     (2) 5/8/2015     C         749366      (2)   (2) Common Stock   749366   $0.00   0   I   See footnote   (4)
2015 Convertible Notes     (3) 5/8/2015     C         675553      (3)   (3) Common Stock   675553   $0.00   0   I   See footnote   (4)
2015 Convertible Notes     (3) 5/8/2015     C         103812      (3)   (3) Common Stock   103812   $0.00   0   I   By spouse  
Warrants   $6.60   5/8/2015     P      445000       5/8/2015   5/8/2020   Common Stock   445000   $0.00   445000   I   See footnote   (4)
Warrants   $6.60   5/8/2015     P      8333       5/8/2015   5/8/2020   Common Stock   8333   $0.00   8333   I   By spouse  

Explanation of Responses:
( 1)  Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
( 2)  The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
( 3)  The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
( 4)  The securities are directly held by jVen Capital, LLC ("jVen Capital"). Mr. Jones is managing member of jVen Capital and may be deemed to have voting and dispositive power over the shares owned by jVen Capital.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
JONES EVAN/ FA
C/O OPGEN, INC.
708 QUINCE ORCHARD ROAD, SUITE 160
GAITHERSBURG, MD 20878


Chief Executive Officer

Signatures
/s/ Timothy C. Dec, Attorney-in-Fact 5/12/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more OpGen Charts.
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more OpGen Charts.